AVANDIA CV Outcomes Study: Thiazolidinedione Intervention With Vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular Disease

Trial Profile

AVANDIA CV Outcomes Study: Thiazolidinedione Intervention With Vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular Disease

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Rosiglitazone (Primary) ; Pioglitazone; Vitamin D analogues
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms TIDE
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 19 Nov 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 11 Aug 2010 New source identified and integrated (United Kingdom Clinical Research Network).
    • 21 Jul 2010 Status change from recruiting to suspended, as reported in a GSK media release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top